| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.1780330111 |
| P698 | PubMed publication ID | 1689161 |
| P50 | author | Robert D. Inman | Q51425953 |
| P2093 | author name string | K W Marshall | |
| B Chiu | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | substance P | Q411041 |
| P304 | page(s) | 87-90 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Substance P and arthritis: analysis of plasma and synovial fluid levels | |
| P478 | volume | 33 |
| Q72085930 | A metabolite of substance P, SP7–11 is involved in the pathogenesis of inflammatory joint disease |
| Q47850527 | A possible role for saliva as a diagnostic fluid in patients with chronic pain |
| Q72099718 | A role for the C-terminal fragment of substance P, SP7−11 in the pathogenesis of arthritis |
| Q74311903 | Abnormalities of somatosensory perception in patients with painful osteoarthritis normalize following successful treatment |
| Q41143394 | Alterations in neurokinin 1 receptor gene expression in models of pain and inflammation |
| Q34779114 | Assessment and management of chronic pain in elderly people |
| Q38267993 | Central Control of Peripheral Joint Inflammation and Heat Hyperalgesia |
| Q55451375 | Changes in biomarkers in equine synovial fluid two weeks after intra-articular hyaluronan treatment: a randomised double-blind clinical trial. |
| Q71806664 | Changes in the Innervation of Rabbit Craniomandibular Joint Tissues Associated with Experimental Induction of Anterior Disk Displacement: Histochemical and Immunohistochemical Studies |
| Q31080210 | Clinical effects of betamethasone and hyaluronan, and of defocalized carbon dioxide laser treatment on traumatic arthritis in the fetlock joints of horses |
| Q44061887 | Concentrations of neuropeptides substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint. A correlation with symptoms, signs and arthrosco |
| Q35822124 | Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides |
| Q37799060 | Disease-modifying antirheumatic and immunoregulatory agents |
| Q67545391 | Effect of substance P and somatostatin on migration of polymorphonuclear (PMN) cells in vitro |
| Q74162517 | Effects of capsaicin in temporomandibular joint arthritis in rats |
| Q34381353 | Endogenous substance P mediates cold water stress-induced increase in interleukin-6 secretion from peritoneal macrophages |
| Q67925056 | Enkephalinase: A physiologic neuroimmunomodulator detected in the synovial fluid |
| Q41897406 | Excitatory amino acids display compartmental disparity between plasma and synovial fluid in clinical arthropathies. |
| Q45024323 | Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies |
| Q73116682 | Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic disorders |
| Q47578201 | High levels of substance P and CGRP in pseudosynovial fluid from patients with aseptic loosening of their hip prosthesis |
| Q41357342 | Human neutrophil Fc receptor-mediated adhesion under flow: a hollow fibre model of intravascular arrest. |
| Q51379645 | Immunohistochemical analysis of the effects of estrogen on intraarticular neurogenic inflammation in a rat anterior cruciate ligament transection model of osteoarthritis. |
| Q24816519 | Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. |
| Q57503396 | Local neurokinin-1 receptor in the knee joint contributes to the induction, but not maintenance, of arthritic pain in the rat |
| Q24514794 | Localisation and characterisation of substance P binding to human synovial tissue in rheumatoid arthritis |
| Q34565970 | Measurement of plasma-derived substance P: biological, methodological, and statistical considerations |
| Q37047237 | Molecular insights into rheumatoid arthritis |
| Q41205044 | Neuroendocrine immune responses to inflammation: the concept of the neuroendocrine immune loop |
| Q60061934 | Neurogenic Mechanisms in Arthritis |
| Q42557784 | Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions |
| Q40932626 | Neuropathogenesis and neuropharmacology of psoriasis |
| Q35832774 | Neuropeptide degrading enzymes in normal and inflamed human synovium. |
| Q57175080 | Neuropeptides: important regulators of joint homeostasis |
| Q70461420 | Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation? |
| Q43146586 | Novel method for determination of substance P levels in unextracted human plasma by using acidification |
| Q28248971 | Open access chemical and clinical probes to support drug discovery |
| Q40931088 | Osteoarthritis in older patients. Optimum treatment |
| Q38792249 | Pain in knee osteoarthritis is associated with variation in the neurokinin 1/substance P receptor (TACR1) gene. |
| Q54255491 | Participation of peripheral tachykinin NK1 receptors in the carrageenan-induced inflammation of the rat temporomandibular joint. |
| Q54000450 | Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen. |
| Q45952571 | Production of interleukin-1 by microglia in response to substance P: role for a non-classical NK-1 receptor |
| Q28367514 | Profile of capsaicin-induced mouse ear oedema as neurogenic inflammatory model: comparison with arachidonic acid-induced ear oedema |
| Q89720415 | Profiling of inflammatory mediators in the synovial fluid related to pain in knee osteoarthritis |
| Q60350078 | Receptor subtypes involved in tachykinin-mediated edema formation☆ |
| Q34085870 | Reciprocal interactions between the neuroendocrine and immune systems during inflammation |
| Q35342904 | Role of substance P in inflammatory arthritis |
| Q64234800 | Skin inflammatory reactions to capsaicin in rheumatoid arthritis patients compared to healthy controls |
| Q74250019 | Soluble recombinant neutral endopeptidase (CD10) as a potential antiinflammatory agent |
| Q36211395 | Substance P and Chronic Pain in Patients with Chronic Inflammation of Connective Tissue |
| Q41264126 | Sympathetic nervous system in chronic joint pain |
| Q34119549 | Tachykinin receptor modulators: novel therapeutics for rheumatoid arthritis |
| Q34803993 | Tachykinins and tachykinin receptors in bone |
| Q28251734 | The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis |
| Q34736462 | The disablement process in rheumatoid arthritis |
| Q72100193 | The effect of endothelin, neuropeptide Y, calcitonin gene‐related peptide and substance P on neutrophil functions |
| Q73980279 | The neurokinin-1 receptor antagonist RP 67580 reduces the sensitization of primary afferents by substance P in the rat |
| Q73189042 | The presence of secretoneurin in human synovium and synovial fluid |
| Q42809987 | The substance P fragment SP-(7-11) increases prostaglandin E2, intracellular Ca2+ and collagenase production in bovine articular chondrocytes |
| Q41757345 | The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles |
| Q34097639 | Topical preparations for chronic disorders of the knee: a review |
| Q73106317 | Unilateral arthritis: contralateral effects |
| Q53786306 | [Peripheral mechanisms of joint pain with special focus on the synovial fibroblast]. |
Search more.